BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND Neurokinin AND Treatment
8 results:

  • 1. Aprepitant Promotes Caspase-Dependent Apoptotic Cell Death and G2/M Arrest through PI3K/Akt/NF-
    Javid H; Afshari AR; Zahedi Avval F; Asadi J; Hashemy SI
    Biomed Res Int; 2021; 2021():8808214. PubMed ID: 34926694
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression.
    Mohammadi F; Javid H; Afshari AR; Mashkani B; Hashemy SI
    Mol Biol Rep; 2020 Jun; 47(6):4263-4272. PubMed ID: 32436041
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The substance P and neurokinin-1 receptor system in human thyroid cancer: an immunohistochemical study.
    Isorna I; Esteban F; Solanellas J; Coveñas R; Muñoz M
    Eur J Histochem; 2020 Apr; 64(2):. PubMed ID: 32363847
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cost-minimization analysis of GSTP1c.313A>G genotyping for the prevention of cisplatin-induced nausea and vomiting: A Bayesian inference approach.
    Macedo LT; Ferrari VE; Carron J; Costa EFD; Lopes-Aguiar L; Lourenço GJ; Lima CSP
    PLoS One; 2019; 14(3):e0213929. PubMed ID: 30870506
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Role of neurokinin 3 Receptor Signaling in Oral Squamous Cell Carcinoma.
    Obata K; Shimo T; Okui T; Matsumoto K; Takada H; Takabatake K; Kunisada Y; Ibaragi S; Yoshioka N; Kishimoto K; Nagatsuka H; Sasaki A
    Anticancer Res; 2017 Nov; 37(11):6119-6123. PubMed ID: 29061792
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature.
    Song JS; Tawa M; Chau NG; Kupper TS; LeBoeuf NR
    BMC Cancer; 2017 Mar; 17(1):200. PubMed ID: 28302100
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy.
    Longo F; Mansueto G; Lapadula V; De Sanctis R; Quadrini S; Grande R; Gori B; Altavilla A; D'Antoni I; Del Signore E; Stumbo L; De Luca C; Cimadon B; Cortesi E; Gamucci T; Di Seri M
    Support Care Cancer; 2011 Aug; 19(8):1159-64. PubMed ID: 20552375
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2.
    Muñoz M; Rosso M; Aguilar FJ; González-Moles MA; Redondo M; Esteban F
    Invest New Drugs; 2008 Apr; 26(2):111-8. PubMed ID: 17906845
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.